Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

NCT01331941 ·Status: COMPLETED ·Phase: PHASE1

Study of AMG 650 in Adult Participants With Advanced Solid Tumors

NCT04293094 ·Status: COMPLETED ·Phase: PHASE1

A Study of AMG 337 in Subjects With Advanced Solid Tumors

NCT01253707 ·Status: COMPLETED ·Phase: PHASE1

A Study of AMG 820 in Subjects With Advanced Solid Tumors

NCT01444404 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors

NCT01235416 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors

NCT02525536 ·Status: COMPLETED ·Phase: PHASE1

An Open Label Treatment Extension Study of AMG 706

NCT00360867 ·Status: TERMINATED ·Phase: PHASE2

AMG 404 in Patients With Advanced Solid Tumors

NCT03853109 ·Status: COMPLETED ·Phase: PHASE1

A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

NCT05094336 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors

NCT06685068 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

AMG 386 Drug-Drug Interaction Study With Paclitaxel

NCT01992341 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors

NCT01137552 ·Status: TERMINATED ·Phase: PHASE1

Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

NCT06333951 ·Status: RECRUITING ·Phase: PHASE1

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

NCT00858377 ·Status: COMPLETED ·Phase: PHASE1

SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

NCT00121290 ·Status: COMPLETED ·Phase: PHASE1

Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors

NCT01386866 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies

NCT02013804 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

NCT01723020 ·Status: COMPLETED ·Phase: PHASE1

SJG-136 in Treating Patients With Advanced Solid Tumors

NCT00103220 ·Status: COMPLETED ·Phase: PHASE1

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00324597 ·Status: UNKNOWN ·Phase: PHASE1

QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors

NCT00974896 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

NCT03355066 ·Status: TERMINATED ·Phase: PHASE1

MG98 in Treating Patients With Advanced Solid Tumors

NCT00003890 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

NCT03600883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study of 23ME-01473 in Patients With Advanced Solid Malignancies

NCT06290388 ·Status: TERMINATED ·Phase: PHASE1/PHASE2